top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (366 p.)
Soggetto topico Clinical and internal medicine
Medicine and Nursing
Soggetto non controllato adenovirus
adoptive T cell therapy
antigen-agnostic vaccination
antitumor immune response
arming
biomarkers
cancer
cancer immune therapy
cancer immunotherapy
cancer therapy
CAR T cell
checkpoint inhibitor
checkpoint inhibitors
class I HLA
clinical trials
colorectal cancer
combination therapy
combinatory therapy
CTLA-4
delivery
DNA methyltransferase inhibitor (DNMTi)
epigenetic silencing
genetic modification
glioblastoma
HER2
herpes simplex virus
HSV-1
immune checkpoint blockade
immune checkpoint inhibitor
immunoediting
immunogenic cell death
immunostimulatory
immunosurveillance
immunotherapy
measles virus
melanoma
multi-stage
n/a
NDV
newcastle disease virus
oncogenic signaling
oncolytic
oncolytic adenovirus
oncolytic virus
oncolytic viruses
pancreatic cancer
pancreatic ductal adenocarcinoma
parvovirus
PD-1
PD-L1
personalized oncolyticvirotherapy
RAS
reovirus
retargeted virus
small molecule
targeting
tropism retargeting
tumor
tumor microenvironment
type I interferon
vaccination
vector engineering
vesicular stomatitis virus
viral mimicry
virotherapy
αvβ6 integrin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (578 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ADAM17
adoptive T cell therapy
AKT
androgens
apoptosis
autoimmune disease
autosomal-dominant hyper IgE syndrome
Bone Marrow Failure Syndromes
breast cancer
cancer
cancer models
cancer progression
cancer-stem cell
CD38
CD4+ T cells
CD8+ T cells
cell cycle
cell hierarchy
chaperones
chemotherapy resistance
cirrhosis
colon cancer
companion animals
comparative oncology
cytokine
cytokine receptor signaling
dynamic programming
endoplasmic reticulum (ER) stress
epidermal growth factor receptor (EGF-R)
ERK1/2
escape mechanisms
gain-of-function mutation
glioblastoma
glioma
growth hormone insensitivity syndrome
heat shock proteins
hedging
hematopoietic cancers
hepatitis C virus (HCV)
hepatocellular carcinoma (HCC)
hepatocyte nuclear factor 4 alpha (HNF4A)
immune check point
immune suppression
immunosuppression
immunotherapy
inflammation
inflammation associated cancer
inflammatory hepatocellular adenomas
interleukin-6
JAK
JAK family of protein tyrosine kinases
JAK2 V617F
knockout
lipopolyplex
lung cancer
lymphocytes
lymphoma
M2 macrophages
melanoma
meta-analysis
metalloprotease
metastasis
microRNA-122 (miR-122)
mitochondria
MPN
mTOR
multiple myeloma
mutations
myeloid cells
myeloid leukemia
n/a
nanoparticle
neoplastic stem cells
NGS
NK cells
nuclear factor erythroid 2-related factor 2 (NRF2)
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
ovarian cancer
oxidative stress (OS)
PD-L1
PEI
pharmacological inhibitor
pharmacological inhibitors
polyethylenimine
post-decision state variable
prolactin
proliferation
prostate cancer
RHOA
risk management
S3I-1757
SH2 domain
shedding
signal transducer and activator of transcription
signal transducer and activator of transcription 3 (STAT3)
siRNA delivery
siRNA/RNAi
small-molecule inhibitors
solid cancers
stabilization
STAT
STAT transcription factors
STAT3
STAT3 inhibitor XIII
STAT5
STAT5 signaling
STAT5B signaling
stem/progenitor cells
stemness
T-cell large granular lymphocytic leukemia
T-cell leukemia
T-cell prolymphocytic leukemia
T-cells
T-PLL
targeted therapy
targeting
therapeutic targeting
therapy resistance
trans-signaling
transaction costs
tumor microenvironment
tumor necrosis factor alpha (TNFα)
tumor suppression
tumor-associated macrophages
tumor-immune cell interactions
tumorigenesis
tyrosine kinase 2
unfolded protein response (UPR)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui